COSM regulatory event: an FDA approval, +34.1%

On August 19, 2020, Cosmos Health Inc. reached its regulatory event. The result was an FDA approval, and the stock moved +34.1% in the window around the event. It had already run +16.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.